Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2050506 | FEBS Letters | 2007 | 7 Pages |
Abstract
The nuclear receptor coactivator RAC3 plays important roles in many biological processes and tumorigenesis. We found that RAC3 is over-expressed in human chronic myeloid leukemia cells K562, which are normally resistant to TRAIL-induced apoptosis. RAC3 down-regulation by siRNA rendered these cells sensitive to TRAIL-induced cell death. In addition to the up-regulation of TRAIL receptors, the process involves Bid, caspases and PARP activation, loss of mitochondrial membrane potential, and release of AIF, cytochrome c and Smac/DIABLO to the cytoplasm. We conclude that RAC3 is required for TRAIL resistance and that this anti-apoptotic function is independent of its role in hormone receptor signaling.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Georgina P. Colo, Roberto R. Rosato, Steven Grant, Mónica A. Costas,